Business Description
Crystalvue Medical Co Ltd
ISIN : TW0006527005
Description
Crystalvue Medical Co Ltd is engaged in manufacturing and production of medical devices including chin rest, digital microscope camera, OCT, fundus camera, gastrointestinal endoscopic disposable devices and tonometer among others. It also provides FundusVue which is a diagnostic instrument for ophthalmologists to inspect and record the patients' retina.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.33 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Interest Coverage | 164.48 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.76 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.3 | |||||
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 22.8 | |||||
| 3-Year Book Growth Rate | 8 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.58 | |||||
| 9-Day RSI | 64.06 | |||||
| 14-Day RSI | 59.97 | |||||
| 6-1 Month Momentum % | 1.97 | |||||
| 12-1 Month Momentum % | -1.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.15 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 196.86 | |||||
| Days Sales Outstanding | 63.89 | |||||
| Days Payable | 53.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.28 | |||||
| Dividend Payout Ratio | 0.58 | |||||
| 3-Year Dividend Growth Rate | -0.4 | |||||
| Forward Dividend Yield % | 2.28 | |||||
| 5-Year Yield-on-Cost % | 4.28 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 2.59 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.73 | |||||
| Operating Margin % | 14.55 | |||||
| Net Margin % | 12.86 | |||||
| FCF Margin % | 11.05 | |||||
| ROE % | 12.44 | |||||
| ROA % | 9.77 | |||||
| ROIC % | 14.96 | |||||
| 3-Year ROIIC % | 13.82 | |||||
| ROC (Joel Greenblatt) % | 21.12 | |||||
| ROCE % | 14.99 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.86 | |||||
| PE Ratio without NRI | 21.85 | |||||
| Shiller PE Ratio | 26.88 | |||||
| Price-to-Owner-Earnings | 108.62 | |||||
| PEG Ratio | 2.66 | |||||
| PS Ratio | 2.8 | |||||
| PB Ratio | 2.61 | |||||
| Price-to-Tangible-Book | 2.64 | |||||
| Price-to-Free-Cash-Flow | 25.4 | |||||
| Price-to-Operating-Cash-Flow | 16.1 | |||||
| EV-to-EBIT | 15.91 | |||||
| EV-to-EBITDA | 12.74 | |||||
| EV-to-Revenue | 2.52 | |||||
| EV-to-FCF | 22.54 | |||||
| Price-to-Projected-FCF | 3.77 | |||||
| Price-to-DCF (Earnings Based) | 1.27 | |||||
| Price-to-DCF (FCF Based) | 2.03 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.73 | |||||
| Price-to-Graham-Number | 1.6 | |||||
| Price-to-Net-Current-Asset-Value | 4.94 | |||||
| Price-to-Net-Cash | 301.67 | |||||
| Earnings Yield (Greenblatt) % | 6.3 | |||||
| FCF Yield % | 3.96 | |||||
| Forward Rate of Return (Yacktman) % | 7.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Crystalvue Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 820.475 | ||
| EPS (TTM) (NT$) | 4.14 | ||
| Beta | 1.22 | ||
| Volatility % | 13.18 | ||
| 14-Day RSI | 59.97 | ||
| 14-Day ATR (NT$) | 1.303368 | ||
| 20-Day SMA (NT$) | 88.74 | ||
| 12-1 Month Momentum % | -1.24 | ||
| 52-Week Range (NT$) | 76.9 - 92.6 | ||
| Shares Outstanding (Mil) | 25.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Crystalvue Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Crystalvue Medical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Crystalvue Medical Co Ltd Frequently Asked Questions
What is Crystalvue Medical Co Ltd(ROCO:6527)'s stock price today?
The current price of ROCO:6527 is NT$90.50. The 52 week high of ROCO:6527 is NT$92.60 and 52 week low is NT$76.90.
When is next earnings date of Crystalvue Medical Co Ltd(ROCO:6527)?
The next earnings date of Crystalvue Medical Co Ltd(ROCO:6527) is .
Does Crystalvue Medical Co Ltd(ROCO:6527) pay dividends? If so, how much?
The Dividend Yield %  of Crystalvue Medical Co Ltd(ROCO:6527) is 2.28% (As of Today), Highest Dividend Payout Ratio of Crystalvue Medical Co Ltd(ROCO:6527) was 1.1. The lowest was 0.15. And the median was 0.44. The  Forward Dividend Yield % of Crystalvue Medical Co Ltd(ROCO:6527) is 2.28%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers